| Clinical data | |
|---|---|
| Trade names | Naphcon-a |
| AHFS/Drugs.com | Monograph |
| Routes of administration |
Topical (solution) |
| ATC code | |
| Identifiers | |
|
|
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| ECHA InfoCard | 100.011.492 |
| Chemical and physical data | |
| Formula | C14H14N2 |
| Molar mass | 210.274 |
| 3D model (Jmol) | |
|
|
|
|
|
|
|
Naphazoline (in the hydrochloride form) is the common name for 2-(1-naphthylmethyl)-2-imidazoline hydrochloride. It is a sympathomimetic agent with marked alpha adrenergic activity. It is a vasoconstrictor with a rapid action in reducing swelling when applied to mucous membrane. It acts on alpha-receptors in the arterioles of the conjunctiva to produce constriction, resulting in decreased congestion. It is an active ingredient in several over-the-counter formulations including Clear Eyes and Naphcon eye drops.
The non-hydrochloride form of Naphazoline has the molecular formula C14H14N2 and a molar mass of 210.28 g/mol. The HCl salt form has a molar mass of 246.73 g/mol.
A few warnings and contraindications that apply to all naphazoline-containing substances intended for medicinal use are:
A possible association with stroke has been suggested.